Zobrazeno 1 - 10
of 1 343
pro vyhledávání: '"Coughlan, L"'
Autor:
Bliss CM; Division of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK.; Systems Immunity University Research Institute, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK., Hulin-Curtis SL; Division of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK., Williams M; Division of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK., Marušková M; Division of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK., Davies JA; Division of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK., Statkute E; Division of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK., Baker AT; Division of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK., Stack L; Division of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK., Kerstetter L; University of Maryland School of Medicine, Department of Microbiology and Immunology, Baltimore, MD 21201, USA., Kerr-Jones LE; Division of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK., Milward KF; Division of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK., Russell G; University of Maryland School of Medicine, Department of Microbiology and Immunology, Baltimore, MD 21201, USA., George SJ; Bristol Medical School, Translational Health Sciences, University of Bristol, Bristol BS2 8HW, UK., Badder LM; Division of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK., Stanton RJ; Systems Immunity University Research Institute, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK.; Division of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK., Coughlan L; University of Maryland School of Medicine, Department of Microbiology and Immunology, Baltimore, MD 21201, USA.; University of Maryland School of Medicine, Center for Vaccine Development and Global Health, Baltimore, MD 21201, USA., Humphreys IR; Systems Immunity University Research Institute, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK.; Division of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK., Parker AL; Division of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK.; Systems Immunity University Research Institute, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK.
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2024 Jul 30; Vol. 32 (3), pp. 101308. Date of Electronic Publication: 2024 Jul 30 (Print Publication: 2024).
Autor:
Bliss CM; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Division of Cancer & Genetics and Systems Immunity University Research Institute, School of Medicine, Cardiff University, Cardiff, UK., Nachbagauer R; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Mariottini C; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Cuevas F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Feser J; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA., Naficy A; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA., Bernstein DI; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA; Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Guptill J; Duke Early Phase Clinical Research Unit, Duke Clinical Research Institute, Durham, NC, USA., Walter EB; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Berlanda-Scorza F; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA., Innis BL; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA., García-Sastre A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; The Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Palese P; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA., Coughlan L; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; University of Maryland School of Medicine, Department of Microbiology and Immunology, Baltimore, MD 21201, USA; University of Maryland School of Medicine, Center for Vaccine Development and Global Health (CVD), Baltimore, MD 21201, USA. Electronic address: lcoughlan@som.umaryland.edu.
Publikováno v:
EBioMedicine [EBioMedicine] 2024 Jun; Vol. 104, pp. 105153. Date of Electronic Publication: 2024 May 27.
Autor:
Coughlan L; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA., Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA. Electronic address: kneuzil@som.umaryland.edu.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2024 May; Vol. 24 (5), pp. 447-449. Date of Electronic Publication: 2024 Feb 05.
Autor:
Del Veliz S; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA., Coughlan L; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA; Center for Vaccine Development and Global Health (CVD), University of Maryland School of Medicine, Baltimore, MD 21201, USA. Electronic address: lcoughlan@som.umaryland.edu.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2024 Jan 03; Vol. 32 (1), pp. 6-8. Date of Electronic Publication: 2023 Dec 11.
Autor:
Mandal S; UK Health Security Agency, London, UK. Electronic address: Sema.Mandal@ukhsa.gov.uk., Simmons R; UK Health Security Agency, London, UK., Ireland G; UK Health Security Agency, London, UK., Charlett A; UK Health Security Agency, London, UK., Desai M; UK Health Security Agency, London, UK., Coughlan L; UK Health Security Agency, London, UK., Powell A; UK Health Security Agency, London, UK., Leeman D; UK Health Security Agency, London, UK; UK Field Epidemiology Training Programme, UK Health Security Agency, London, UK., Williams C; Public Health Wales, Cardiff, UK., Neill C; Public Health Agency, Belfast, UK., O'Leary MC; Public Health Scotland, Glasgow, UK., Sawyer C; Public Health Wales, Cardiff, UK., Rowley F; UK Field Epidemiology Training Programme, UK Health Security Agency, Cardiff, UK; Public Health Wales, Cardiff, UK., Harris C; Public Health Wales, Cardiff, UK., Houlihan C; UK Health Security Agency, London, UK; University College London, UK., Gordon C; UK Health Security Agency, London, UK., Rampling T; UK Health Security Agency, London, UK., Callaby H; UK Health Security Agency, London, UK; Medical Sciences, University of Aberdeen, Aberdeen, UK., Hoschler K; UK Health Security Agency, London, UK., Cogdale J; UK Health Security Agency, London, UK., Renz E; UK Health Security Agency, London, UK., Sebastianpilli P; UK Health Security Agency, London, UK., Thompson C; UK Health Security Agency, London, UK., Talts T; UK Health Security Agency, London, UK., Celma C; UK Health Security Agency, London, UK., Davies EA; Manchester Medical Microbiology Partnership, Manchester Royal Infirmary, Manchester, UK., Ahmad S; Public Health Scotland, Glasgow, UK; Manchester Medical Microbiology Partnership, Manchester Royal Infirmary, Manchester, UK., Machin N; Manchester Medical Microbiology Partnership, Manchester Royal Infirmary, Manchester, UK., Gifford L; Public Health Wales, Cardiff, UK., Moore C; Public Health Wales, Cardiff, UK., Dickson EM; Public Health Scotland, Glasgow, UK., Divala TH; Public Health Scotland, Glasgow, UK., Henderson D; Public Health Scotland, Glasgow, UK., Li K; Belfast Health and Social Care Trust, Belfast, UK., Broadbent P; Public Health Scotland, Glasgow, UK., Ushiro-Lumb I; UK Health Security Agency, London, UK; NHS Blood and Transplant, London, UK., Humphreys C; UK Health Security Agency, London, UK., Grammatikopoulos T; King's College Hospital NHS Foundation Trust, London, UK., Hartley J; Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK., Kelgeri C; Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK., Rajwal S; Leeds Teaching Hospitals NHS Trust, Leeds, UK., Okike I; Derbyshire Healthcare NHS Foundation Trust, Derby, UK., Kelly DA; Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK., Guiver M; Manchester Medical Microbiology Partnership, Manchester Royal Infirmary, Manchester, UK., Borrow R; UK Health Security Agency, London, UK; Manchester Medical Microbiology Partnership, Manchester Royal Infirmary, Manchester, UK., Bindra R; UK Health Security Agency, London, UK., Demirjian A; UK Health Security Agency, London, UK; Evelina Children's Hospital, London, UK; King's College London, London, UK., Brown KE; UK Health Security Agency, London, UK., Ladhani SN; UK Health Security Agency, London, UK., Ramsay ME; UK Health Security Agency, London, UK., Bradley DT; Public Health Agency, Belfast, UK., Gjini A; Public Health Wales, Cardiff, UK., Roy K; Public Health Scotland, Glasgow, UK., Chand M; UK Health Security Agency, London, UK., Zambon M; UK Health Security Agency, London, UK., Watson CH; UK Health Security Agency, London, UK.
Publikováno v:
The Lancet. Child & adolescent health [Lancet Child Adolesc Health] 2023 Nov; Vol. 7 (11), pp. 786-796. Date of Electronic Publication: 2023 Sep 26.
Autor:
Puente-Massaguer E; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Vasilev K; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Beyer A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Loganathan M; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Francis B; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Scherm MJ; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Arunkumar GA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., González-Domínguez I; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Zhu X; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Wilson IA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.; Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Coughlan L; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.; Center for Vaccine Development and Global Health (CVD), University of Maryland School of Medicine, Baltimore, MD 21201, USA., Sun W; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Palese P; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Publikováno v:
Science advances [Sci Adv] 2023 Sep 15; Vol. 9 (37), pp. eadi4753. Date of Electronic Publication: 2023 Sep 13.
Autor:
Schneider C; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA; Graduate Program in Life Sciences (GPILS), Molecular Microbiology and Immunology Program, University of Maryland School of Medicine Baltimore, Baltimore, MD 21201, USA., Coughlan L; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA; Center for Vaccine Development and Global Health (CVD), University of Maryland School of Medicine, Baltimore, MD 21201, USA. Electronic address: lcoughlan@som.umaryland.edu.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2023 Jul 05; Vol. 31 (7), pp. 1865-1867. Date of Electronic Publication: 2023 May 17.
Autor:
Amanat F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Clark J; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, New York, USA., Carreño JM; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, New York, USA., Strohmeier S; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Yellin T; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Meade PS; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, New York, USA., Bhavsar D; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, New York, USA., Muramatsu H; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Sun W; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Coughlan L; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Center for Vaccine Development and Global Health (CVD), University of Maryland School of Medicine, Baltimore, Maryland, USA., Pardi N; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Publikováno v:
Journal of virology [J Virol] 2023 Mar 30; Vol. 97 (3), pp. e0166422. Date of Electronic Publication: 2023 Feb 13.
Autor:
Haupt R; Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, MD, USA.; Center for Pathogen Research, School of Medicine, University of Maryland, Baltimore, MD, USA.; Therapeutic Discovery Branch, Molecular Biology Division, USAMRIID, Fort Detrick, MD, USA., Baracco L; Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, MD, USA.; Center for Pathogen Research, School of Medicine, University of Maryland, Baltimore, MD, USA., Harberts EM; Department of Microbial Pathogenesis, School of Dentistry, University of Maryland, Baltimore, MD, USA., Loganathan M; Department of Microbiology, Icahn School of Medicine, New York, NY, USA., Kerstetter LJ; Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, MD, USA., Krammer F; Department of Microbiology, Icahn School of Medicine, New York, NY, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Coughlan L; Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, MD, USA.; Center for Vaccine Development and Global Health (CVD), University of Maryland School of Medicine, Baltimore, MD, 21201, USA., Ernst RK; Department of Microbial Pathogenesis, School of Dentistry, University of Maryland, Baltimore, MD, USA., Frieman MB; Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, MD, USA. mfrieman@som.umaryland.edu.; Center for Pathogen Research, School of Medicine, University of Maryland, Baltimore, MD, USA. mfrieman@som.umaryland.edu.
Publikováno v:
Scientific reports [Sci Rep] 2023 Jan 13; Vol. 13 (1), pp. 715. Date of Electronic Publication: 2023 Jan 13.
Autor:
Coughlan, L, Sridhar, S, Payne, R, Edmans, E, Milicic, A, Venkatraman, N, Lugonja, B, Clifton, L, Qi, C, McMichael, A, Folegatti, PM, Lawrie, AM, Roberts, R, de Graaf, H, Sukhtankar, P, Faust, SN, Lewis, DJM, Lambe, T, Hill, AVS, Gilbert, SC
Publikováno v:
EBioMedicine, Vol 29, Iss, Pp 146-154 (2018)
EBioMedicine
EBioMedicine
Background T-cell responses against highly conserved influenza antigens have been previously associated with protection. However, these immune responses are poorly maintained following recovery from influenza infection and are not boosted by inactiva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e5983940aa775dfd7965f632eb46586
http://www.sciencedirect.com/science/article/pii/S2352396418300653
http://www.sciencedirect.com/science/article/pii/S2352396418300653